Rosetta Leverages Borland Application Lifecycle Management Products
News Jun 07, 2006
Borland Software Corporation has announced that Rosetta Biosoftware is using Borland's Application Lifecycle Management (ALM) products to deliver software for the pharmaceutical and biotech industries.
Rosetta Biosoftware leverages Borland's tightly integrated CaliberRM®, StarTeam® and Together® products along with the company's Consulting and Education Services to manage its critical software development processes.
In recognition of its use of information technology to benefit society, Rosetta Biosoftware was recently named an IDG Computerworld Honors Program Laureate.
Rosetta Biosoftware is currently using Borland's ALM products to streamline and automate the processes of requirements management, software change and configuration management as well as visual modeling and architectural design.
The processes are critical to the ongoing development of its flagship product, the Rosetta Resolver® system.
The Rosetta Resolver system is designed to offer life science researchers an analysis and data management framework for gene expression.
Rosetta Biosoftware's primary goal is to empower researchers in drug discovery and development to conduct research for improving the quality of human life.
Because its customers rely on the Resolver system to enable the drug discovery process, they need confidence in the software's accuracy and its ability to reproduce analysis results.
Customers also need confidence in Rosetta's methods for developing and validating the software, which means those development and validation methods must be transparent and well-documented.
"Early on we realized we needed a comprehensive ALM solution like the one Borland provides us to integrate, automate and document our core development processes," explained Jim Pearson, manager of quality assurance at Rosetta Biosoftware.
"The life sciences industry rapidly changes as information technology is applied to more areas of research."
"It is imperative that we're able to quickly deliver new features and functionality to address this rapidly evolving market."
"To do that we needed a powerful but flexible system that can support our rigorous requirements and easily adapt to our methodologies."
Rosetta Biosoftware leverages the tightly integrated and customizable Borland CaliberRM technology to automate its specific requirements processes and to track requirements from elicitation through final delivery.
Once the business, technical, functional and operational requirements are entered into the Borland CaliberRM system, stakeholders across the organization can map their individual efforts back to the requirements and collaborate with each other more effectively.
In addition, Borland StarTeam provides a platform for the entire software delivery process.
It is designed to promote team communication and collaboration through automated workflows and centralized control of all project assets.
Rosetta Biosoftware also enables its customers to leverage this system to enter escalation and enhancement requests for the Resolver product, and then extract web pages to view the progress of their change requests.
The Rosetta Biosoftware team is also using Borland Together to help bridge the communication gap between business and IT stakeholders.
Bioethics Council Rules Heritable Genome Editing "Ethically Acceptable" In Certain CircumstancesNews
A leading UK bioethics advisory body has weighed in on the debate around human genetic modification, concluding that heritable genome editing – modifying the DNA of an egg, sperm or embryo with changes that will be passed on to future generations – could be ‘morally permissible’ in humans, provided key ethical tests are met.
Genetic Factors Leading to Rare Bone Fusion Disorder IdentifiedNews
Genome sequencing establishes multiple genes responsible for a rare condition that cause bone fusionREAD MORE
Hay Fever Risk Genes Overlap with Autoimmune DiseaseNews
In a large international study involving almost 900,000 participants, researchers from the University of Copenhagen and COPSAC have found new risk genes for hay fever. It is the largest genetic study so far on this type of allergy, which affects millions of people around the world.READ MORE